UK cancer monoclonal antibodies market is estimated to grow at a CAGR of 8.2% during the forecast period. The increasing prevalence of cancer and rising biomedical researches are some factors accelerating market growth. As per the World Health Organization (WHO), the number of new cancer incidences reported in the country was 446,942 in 2018. This includes prostate (12.6%), breast (12.4%), lung (11.7%), colorectum (10.7%), and others. These significant cancer incidences are leading to an increasing demand for targeted cancer therapies including monoclonal antibodies that serve as one of the potential alternatives to find and destroy cancer cells.
Request a free sample of our report on UK Cancer Monoclonal Antibodies Market: https://www.omrglobal.com/request-sample/uk-cancer-monoclonal-antibodies-market
It is one of the established therapeutic strategies for both solid tumors and hematologic malignancies. Some monoclonal antibody drugs that are available with their generic names in the UK include rituximab (Mabthera), trastuzumab (Herceptin), bevacizumab (Avastin), and pertuzumab (Perjeta). MabThera was the first monoclonal antibody therapeutics that aims to target cells containing CD20 marker on their surface. Such cells are central to several blood cancers, which include common types of leukaemia and lymphoma.
A full report of UK Cancer Monoclonal Antibodies Market is available at https://www.omrglobal.com/industry-reports/uk-cancer-monoclonal-antibodies-market
UK Cancer Monoclonal Antibodies Market Segmentation
By Type
• Naked
• Conjugated
• Others (Bispecific)
By Application
• Breast Cancer
• Liver Cancer
• Blood Cancer
• Brain Cancer
• Colorectal Cancer
• Others
Company Profiles
• Amgen, Inc.
• AstraZeneca plc
• GlaxoSmithKline plc
• Johnson & Johnson Services, Inc.
• Mylan N.V.
• Napp Pharmaceuticals,Ltd.
• Orchard Therapeutics plc
• Pfizer, Inc.
• Shire Pharmaceuticals Group plc
• Sitryx Therapeutics, Ltd.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-cancer-monoclonal-antibodies-market
About us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404